Results 1 to 10 of about 396,504 (303)

Transporter-Mediated Drug Delivery

open access: yesMolecules, 2023
Transmembrane transport of small organic and inorganic molecules is one of the cornerstones of cellular metabolism. Among transmembrane transporters, solute carrier (SLC) proteins form the largest, albeit very diverse, superfamily with over 400 members ...
Gergely Gyimesi, Matthias A. Hediger
doaj   +5 more sources

Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia [PDF]

open access: yesFrontiers in Pharmacology, 2022
Hypoxia, an essential feature of high-altitude environments, has a significant effect on drug metabolism. The hypoxia–gut microbiota–CYP450/drug transporter axis is emerging as a vital factor in drug metabolism.
Xue Bai   +9 more
doaj   +2 more sources

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy [PDF]

open access: yesPharmaceutics, 2023
The purpose of this literature review is to comprehensively summarize changes in the expression of phase II drug-metabolizing enzymes and drug transporters in both the pregnant woman and the placenta.
Christine Gong   +3 more
doaj   +2 more sources

Kidney Ischemia/Reperfusion Injury Induces Changes in the Drug Transporter Expression at the Blood–Brain Barrier in vivo and in vitro [PDF]

open access: yesFrontiers in Physiology, 2020
Ischemia/reperfusion injury is a major cause of acute kidney injury (AKI). AKI is characterized by a sudden decrease in kidney function, systemic inflammation, oxidative stress, and dysregulation of the sodium, potassium, and water channels.
Malgorzata Burek   +7 more
doaj   +2 more sources

Drug transporter mRNA expression and genital inflammation in South African women on oral pre-exposure prophylaxis (PrEP) [PDF]

open access: yesAIDS Research and Therapy
Globally HIV remains a major public health problem. In sub-Saharan Africa most new HIV infections occur in adolescent girls and young women. Previously tested antiretroviral drugs as different pre-exposure prophylaxis (PrEP) formulations have shown ...
Nomusa M. Zondo   +9 more
doaj   +2 more sources

Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance [PDF]

open access: yesPharmaceutics, 2020
The pharmacokinetics of a drug is dependent upon the coordinate work of influx transporters, enzymes and efflux transporters (i.e., transporter-enzyme interplay). The transporter–enzyme interplay may occur in liver, kidney and intestine.
Yiting Yang, Xiaodong Liu
doaj   +2 more sources

Mechanistic in vitro studies indicate that the clinical drug–drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3

open access: yesPharmacology Research & Perspectives, 2023
Previous use of a mechanistic static model to accurately quantify the increased rosuvastatin exposure due to drug–drug interaction (DDI) with coadministered atazanavir underpredicted the magnitude of area under the plasma concentration–time curve ratio ...
Robert Elsby   +5 more
doaj   +1 more source

Characteristics of novel polymer based on pseudo-polyamino acids GluLa-DPG-PEG600: binding of albumin, biocompatibility, biodistribution and potential crossing the blood-brain barrier in rats [PDF]

open access: yesThe Ukrainian Biochemical Journal, 2017
The aim of our work was to study biological properties of the polymer based on pseudo-polyamino acids GluLa-DPG-PEG600, its ability to bind albumin, as well as its localization in rat body and influence on physio­logical and functional state of rat ...
B. O. Chekh   +5 more
doaj   +1 more source

The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy

open access: yesPharmaceutics, 2023
Transporter-mediated drug resistance is a major obstacle in anticancer drug delivery and a key reason for cancer drug therapy failure. Membrane solute carrier (SLC) transporters play a crucial role in the cellular uptake of drugs.
Elena Puris, Gert Fricker, Mikko Gynther
doaj   +1 more source

Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer

open access: yesCells, 2020
An abnormality in hedgehog (Hh) signaling has been implicated in the progression of prostate cancer (PCa) to a more aggressive and therapy-resistant disease.
Santosh Kumar Singh   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy